Evolution and current status of the subclassification of intermediate hepatocellular carcinoma

doi:10.4240/wjgs.v12.i3.85

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7093)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-8) series.

Item

Count

PDF

439

WORD

174

HTML

3706

Tables (1-8)

356

Sum=4675

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

916

Download

1502

Sum=2418

Mar 27, 2020 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Surg. Mar 27, 2020; 12(3): 85-92
Published online Mar 27, 2020. doi: 10.4240/wjgs.v12.i3.85

Table 1 Bolondi criteria

BCLC sub-stage	B1	B2	B3	B4
CPT score	5-7	5-6	7	8-9¹
Beyond Milan and within Ut-7	In	Out	Out	Any
ECOG (tumor related) PS	0	0	0	0-1
PVT	No	No	No	No
1^st option	TACE	TACE or TARE		BSC
Alternative	LT TACE + ablation	SOR	Research trials TACE SOR	LT²

¹With severe/refractory ascites and/or jaundice.

²Only if Up-to-7 IN and PS0. CPT: Child Pugh score; BSC: Best supportive care; LT: Liver transplantation; SOR: Sorafenib; TACE: Transcatheter arterial chemoembolization; TARE: Transarterial radioembolization; PVT: Portal vein thrombosis; Ut-7: Up to-7 criteria.

Citation: Yi PS, Wang H, Li JS. Evolution and current status of the subclassification of intermediate hepatocellular carcinoma. World J Gastrointest Surg 2020; 12(3): 85-92
URL: https://www.wjgnet.com/1948-9366/full/v12/i3/85.htm
DOI: https://dx.doi.org/10.4240/wjgs.v12.i3.85